Stockreport

Soliton Announces Submission for IRB Approval of Pivotal Cellulite Trial Protocol

Soliton, Inc.  (SOLY) 
PDF HOUSTON, July 16, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technol [Read more]